Form 8-K - Current report:
SEC Accession No. 0001493152-21-032854
Filing Date
2021-12-30
Accepted
2021-12-30 16:32:23
Documents
12
Period of Report
2021-12-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 34120
  Complete submission text file 0001493152-21-032854.txt   206114

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clsn-20211230.xsd EX-101.SCH 3022
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clsn-20211230_lab.xml EX-101.LAB 34240
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clsn-20211230_pre.xml EX-101.PRE 22357
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3611
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15911 | Film No.: 211533218
SIC: 2834 Pharmaceutical Preparations